Novo Nordisk A/S got a warning letter from the US Food and Drug Administration for not reporting all suspected side effects ...

The FDA issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side ...

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

The previously unreported events include two deaths and a suicide, cases that the Ozempic maker says have been assessed.

Long-Term Effects of Ozempic This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even ...

Novo Nordisk (NVO) stock dropped 27% YTD after FDA warning letter cited failure to report semaglutide side effects, including three deaths and one suicide.

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side effects of the drugs.

Less than a month after the US Food and Drug Administration said a TV advertisement for Novo Nordisk A/S’ Wegovy weight-loss ...

Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...

The US FDA has issued a warning letter to Novo Nordisk after finding delays in reporting serious adverse events linked to ...

These brain areas are also linked to impulsivity and emotional control in people with ADHD. By reducing food cravings and constant thoughts about eating, GLP⁠-1s may help some people feel more focused ...